论文部分内容阅读
Novo Nordisk-established in 1923 A focused, biotech-based healthcare company · Global leader in diabetes care ·Leading positions in haemophilia and growth disorders· Approx.35,000 employees · Production on 5 continents · Sales in 100 countries · 2012: USD 13.5 billion · Stable double-digit sales growth since 2002 · Market cap: USD 52.5 billion (2011) · Value-based management system …one of Denmarks main users of experimental animals In 2000 Novo Nordisk held the first in a series of workshops with external experts The purpose of the workshop was: · To establish the basic needs of: mice, rats, guinea pigs, rabbits, and dogs · To prioritise the 10 most important needs of the experimental animal to be met · To make proposals for how the needs could be met